Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.67 |
| ▸ | LMNA | P02545 | 1/20 | 0.67 |
| ▸ | ALB | P02768 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.67 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.67 |
| ▸ | BLM | P54132 | 1/20 | 0.67 |
| ▸ | TK1 | P04183 | 4/20 | 0.59 |
| ▸ | BCHE | P06276 | 7/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26731814 | 1.00 | ALDH1A1 (0.67) | ALDH1A1LMNAALBPOLBADRA1A | |
| SCHEMBL26309128 | 0.91 | POLB (0.62) | ALDH1A1LMNAALBPOLBADRA1A | |
| SCHEMBL26731712 | 0.91 | POLB (0.62) | ALDH1A1LMNAALBPOLBADRA1A | |
| Stavudine Triphosphate SCHEMBL26731736 | 0.89 | POLB (0.60) | ALDH1A1LMNAALBPOLBADRA1A | |
| Stavudine Triphosphate SCHEMBL987898 | 0.89 | POLB (0.60) | ALDH1A1LMNAALBPOLBADRA1A | |
| SCHEMBL26309146 | 0.86 | POLB (0.56) | ALDH1A1LMNAALBPOLBADRA1A | |
| Stavudine SCHEMBL285043 | 0.84 | ALDH1A1 (0.90) | ALDH1A1LMNAALBPOLBADRA1A | |
| Stavudine SCHEMBL987896 | 0.84 | ALDH1A1 (0.90) | ALDH1A1LMNAALBPOLBADRA1A | |
| SCHEMBL3057283 | 0.84 | ALDH1A1 (0.72) | ALDH1A1LMNAALBPOLBADRA1A | |
| SCHEMBL10446974 | 0.84 | ALDH1A1 (0.71) | ALDH1A1LMNAALBPOLBADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 469 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025078829-A1 | PRINTING INK | FUJIFILM SPECIALITY INK SYSTEMS LIMITED (GB) | 2025-04-17 | — | — | WO | claimed |
| WO-2025078827-A1 | PRINTING INK | FUJIFILM SPECIALITY INK SYSTEMS LIMITED (GB) | 2025-04-17 | — | — | WO | claimed |
| WO-2025046237-A1 | PRINTING INK | FUJIFILM SPECIALITY INK SYSTEMS LIMITED (GB) | 2025-03-06 | — | — | WO | claimed |
| US-20240368417-A1 | PRINTING INK | FUJIFILM SPECIALITY INK SYSTEMS LIMITED (GB) | 2024-11-07 | — | — | US | claimed |
| US-20240254348-A1 | PRINTING INK | FUJIFILM SPECIALITY INK SYSTEMS LIMITED (GB) | 2024-08-01 | — | — | US | claimed |
| EP-4334401-A1 | PRINTING INK | Fujifilm Speciality Ink Systems Limited (GB) | 2024-03-13 | — | — | EP | claimed |
| EP-4320200-A1 | PRINTING INK | Fujifilm Speciality Ink Systems Limited (GB) | 2024-02-14 | — | — | EP | claimed |
| WO-2023156771-A1 | INKJET INK | FUJIFILM SPECIALITY INK SYSTEMS LIMITED (GB) | 2023-08-24 | — | — | WO | claimed |
| WO-2022234290-A1 | PRINTING INK | FUJIFILM SPECIALITY INK SYSTEMS LIMITED (GB) | 2022-11-10 | — | — | WO | claimed |
| WO-2022214814-A1 | PRINTING INK | FUJIFILM SPECIALITY INK SYSTEMS LIMITED (GB) | 2022-10-13 | — | — | WO | claimed |
| WO-2007129017-A1 | A PRINTING INK | SERICOL LIMITED (GB) | 2007-11-15 | — | — | WO | claimed |
| WO-2007125273-A1 | A PRINTING INK | SERICOL LIMITED (GB) | 2007-11-08 | — | — | WO | claimed |
| WO-2007111567-A1 | COMPRESSION-MOULDED TRAY AND METHOD OF PRODUCING A FIBRE TRAY | ROTTNEROS AB (SE) | 2007-10-04 | — | — | WO | claimed |
| US-20060127879-A1 | Electrodynamic profiling of genomic response in the cell | FUCCIONE ANTHONY S | 2006-06-15 | — | — | US | claimed |
| US-20040138167-A1 | Method of treating HIV infection and related secondary infections thereof | BURCOGLU ARSINUR | 2004-07-15 | — | — | US | claimed |
| US-20030013669-A1 | Method of treating HIV infection and related secondary infections thereof | BURCOGLU ARSINUR (US) | 2003-01-16 | — | — | US | claimed |
| EP-1202750-A4 | METHOD OF TREATING HIV INFECTION AND RELATED SECONDARY INFECTIONS THEREOF | BURCOGLU ARSINUR (US) | 2002-10-16 | — | — | EP | claimed |
| EP-1202750-A1 | METHOD OF TREATING HIV INFECTION AND RELATED SECONDARY INFECTIONS THEREOF | BURCOGLU, Arsinur (US) | 2002-05-08 | — | — | EP | claimed |
| US-5962271-A | TEMPLATE SWITCHING OLIGONUCLEOTIDE CAPABLE OF INTERACTING WITH 5' CAP STRUCTURE OF MESSENGER RNA-COMPLEMENTARY DNA HYBRID; SERVES AS TEMPLATE FOR ADDITIONAL REVERSE TRANSCRIPTION REACTIONS | CLOUTECH LABORATORIES, INC. (US) | 1999-10-05 | — | — | US | claimed |
| WO-1998048843-A1 | METHOD OF TREATING HIV INFECTION AND RELATED SECONDARY INFECTIONS THEREOF | BURCOGLU ARSINUR (US) | 1998-11-05 | — | — | WO | claimed |